» Articles » PMID: 33131239

COVID-19 and Sickle Cell Disease

Overview
Journal Haematologica
Specialty Hematology
Date 2020 Nov 2
PMID 33131239
Citations 16
Authors
Affiliations
Soon will be listed here.
Citing Articles

Double Trouble: COVID-19 Infection Exacerbates Sickle Cell Crisis Outcomes in Hospitalized Patients-Insights from National Inpatient Sample 2020.

Bodla Z, Hashmi M, Niaz F, Auyeung A, Oyetoran A, Khalil M Hematol Rep. 2024; 16(3):421-430.

PMID: 39051414 PMC: 11270312. DOI: 10.3390/hematolrep16030041.


A Comprehensive Study on the Hematological Progression of Sickle Cell Disease Patients with COVID-19 at the Center for Research and Control of Sickle Cell Disease, Bamako.

Guindo A, Sarro Y, Kene S, Toure B, Koya A, Keita I J Blood Res Hematol Dis. 2024; 9(1).

PMID: 38846172 PMC: 11154848.


Acute Chest Syndrome in a Patient With Sickle Cell Disease: A Case Report.

Alarcon Sisamon S, Ordas Miguelez M, Lopez Pena A, Rodriguez Sanz J Open Respir Arch. 2024; 6(1):100300.

PMID: 38414581 PMC: 10897885. DOI: 10.1016/j.opresp.2024.100300.


Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.

Pereira L, da Silva M, Germano C, Estevao I, Melo D Front Med (Lausanne). 2023; 10:1144226.

PMID: 37200963 PMC: 10187638. DOI: 10.3389/fmed.2023.1144226.


Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID-19 infection.

Fisher L, Asnani M EJHaem. 2023; 4(1):37-44.

PMID: 36819174 PMC: 9928646. DOI: 10.1002/jha2.636.


References
1.
Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, Dean D . Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000; 342(25):1855-65. DOI: 10.1056/NEJM200006223422502. View

2.
Naymagon L, Berwick S, Kessler A, Lancman G, Gidwani U, Troy K . The emergence of methemoglobinemia amidst the COVID-19 pandemic. Am J Hematol. 2020; 95(8):E196-E197. PMC: 7276830. DOI: 10.1002/ajh.25868. View

3.
Connors J, Levy J . Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020; 18(7):1559-1561. PMC: 9770920. DOI: 10.1111/jth.14849. View

4.
Shet A, Thein S . A Growing Population of Older Adults with Sickle Cell Disease. Clin Geriatr Med. 2019; 35(3):349-367. PMC: 10757270. DOI: 10.1016/j.cger.2019.03.006. View

5.
Mehra M, Desai S, Ruschitzka F, Patel A . RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020; . PMC: 7255293. DOI: 10.1016/S0140-6736(20)31180-6. View